The short version
- Why people research itFocus, memory, neuroprotection, mood and stress resilience.
- What the evidence isNo human trials: development stopped at preclinical, so the ceiling on any claim here is a rodent model — and these transfer poorly.
- What to watchA seizure or muscle twitching.
How Sunifiram works
Sunifiram is not a racetam and it does not contain a pyrrolidone ring. It is 1-(4-benzoylpiperazin-1-yl)propan-1-one — a piperazine with a benzoyl group on one nitrogen and a propanoyl on the other — C14H18N2O2, molecular weight 246.30, computed XLogP 1.1, topological polar surface area 40.6 Å2 National Center for Biotechnology Information 2026.
Here is a fact worth knowing before you buy any of it. Nefiracetam is also C14H18N2O2 with a molecular weight of 246.30 National Center for Biotechnology Information 2026. Same formula, same mass, completely different scaffold — nefiracetam is an anilide of a pyrrolidone, sunifiram a diacylpiperazine.
Reported as roughly 1,000× more potent than piracetam by weight in rodent models.
- Oral
On the goal map: Glutamatergic & synaptic plasticity (Focus, memory & cognition)
Research on Sunifiram4 evidence notes: clinical, correlative, mechanism
Each note is labeled by the kind of evidence it stands on. Unproven is not ineffective: a missing trial means nobody has run it yet. How the evidence tiers work
Human clinical evidence
No human trials: development stopped at preclinical, so the ceiling on any claim here is a rodent model — and these transfer poorly.
No completed human trial
Correlative data
Reported experience is of a sharp acute effect on focus, with a short duration. The safety record is community reports only — there is no toxicology in humans at all, which for a glutamatergic compound is a meaningful gap.
How the mechanism reads
A piperazine derivative, structurally unrelated to the racetams despite being grouped with them. Rodent work suggests AMPA receptor potentiation and cholinergic activity at roughly a thousand times piracetam's potency.
Experimental, animal or cellAmpakine potency is a double-edged mechanism: strong AMPA potentiation is the same pharmacology that raises excitotoxicity concerns, and no one has characterized where that line sits in humans.
Mechanistic
Sources
- Ghelardini C, Galeotti N, Gualtieri F. DM235 (sunifiram): a novel nootropic with potential as a cognitive enhancer.. Naunyn Schmiedebergs Arch Pharmacol 2002 · PMID 12070754
- Galeotti N, Ghelardini C, Pittaluga A. AMPA-receptor activation is involved in the antiamnesic effect of DM 232 (unifiram) and DM 235 (sunifiram).. Naunyn Schmiedebergs Arch Pharmacol 2003 · PMID 14600801
- Romanelli MN, Galeotti N, Ghelardini C. Pharmacological characterization of DM232 (unifiram) and DM235 (sunifiram), new potent cognition enhancers.. CNS Drug Rev 2006 · PMID 16834757
- Moriguchi S, Tanaka T, Narahashi T. Novel nootropic drug sunifiram enhances hippocampal synaptic efficacy via glycine-binding site of N-methyl-D-aspartate receptor.. Hippocampus 2013 · PMID 23733502
- Lanza M, Bonnafous C, Colombo S. Characterization of a novel putative cognition enhancer mediating facilitation of glycine effect on strychnine-resistant sites coupled to NMDA receptor complex.. Neuropharmacology 1997 · PMID 9294970
- National Center for Biotechnology Information. PubChem Compound Summary for CID 4223812, Sunifiram.. PubChem, retrieved 2026
- National Center for Biotechnology Information. PubChem Compound Summary for CID 71157, Nefiracetam.. PubChem, retrieved 2026
Sunifiram safety basicsWho should avoid it, what to expect, what to watch
Avoid if
- Seizure disorder: AMPA receptor potentiation lowers the threshold for runaway firing.
- Anxiety disorder or bipolar disorder: glutamate drive can worsen both.
- Stimulant or other ampakine use: AMPA stacking is unstudied.
- Pregnancy: a potent AMPA modulator with no human data should not meet a fetus.
- Expecting human safety data: none exist for this compound.
What’s expected
- Unknown in people; rodent data show memory gains at tiny doses.
- If AMPA modulation works: quicker thinking and light alertness.
- Possible insomnia or headache.
Watch for
- A seizure or muscle twitching.
- Panic or sustained agitation.
- Several nights of poor sleep.
- Racing thoughts.
Labs that tell you it’s working
- Comprehensive Metabolic Panel (CMP)
- Magnesium
- Cortisol
- TSH (Thyroid-Stimulating Hormone)
Sunifiram is a piperazine ampakine that positively modulates AMPA receptors; with no human data, excitability is the central predicted risk. PMID 12070754 PMID 16834757
Bloodwork to runHow you would know it is working: 8 tests in one order, code CAMERON
A panel picked from how it works and what it can move: the tests, and why each is on it.
Code CAMERON applies automatically. The before and after schedule and how to read the results are in the Skool lesson.
Sunifiram FAQ4 common questions
- Is Sunifiram approved for human use?
- No. Sunifiram is a research compound. No completed randomized human trial has given it yet.
- What is Sunifiram researched for?
- Focus, memory, neuroprotection, mood and stress resilience.
- Which labs show whether it's doing anything?
- Comprehensive Metabolic Panel; Magnesium; Cortisol; TSH: a baseline before you start and a recheck after. The panel on this page orders them in one cart.
- Where's the full protocol?
- In the Skool lesson for Sunifiram: the protocol, dose and schedule, timing, what to stack, the cycle answer, the bloodwork plan and the cheat sheet. Protocol & dosing live there, not on the public site.



